Ascendis Pharma A/S (ASND) vs Jazz Pharmaceuticals PLC (JAZZ)
Ascendis Pharma A/S and Jazz Pharmaceuticals PLC are both Biotechnology companies. Ascendis Pharma A/S and Jazz Pharmaceuticals PLC are of similar size ($15.7B and $15.3B). Jazz Pharmaceuticals PLC trades at the lower P/E: 15.6× against 16.3×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against 12.6%. Ascendis Pharma A/S has the higher net margin (71.2% vs 20.5%) and the higher return on invested capital (15.1% vs 8.06%). Across the 21 metrics below, Ascendis Pharma A/S leads on 13 and Jazz Pharmaceuticals PLC on 8.
Valuation
Profitability
| Metric | ASND | JAZZ | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.26% | 88.42% | 65.16% |
| Operating margin | 24.84% | 19.49% | 0.00% |
| Net margin | 71.20% | 20.45% | 0.00% |
| Free cash flow margin | 31.97% | 30.79% | 0.00% |
| Return on equity | 118.44% | 22.11% | (57.72%) |
| Return on assets | 44.34% | 8.54% | (49.22%) |
| Return on invested capital | 15.07% | 8.06% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack